Fulgent Genetics Dirección
Dirección controles de criterios 2/4
El CEO de Fulgent Genetics es Ming Hsieh , nombrado en May 2016, tiene una permanencia de 8.5 años. compensación anual total es $5.31M, compuesta por 18.8% salario y 81.2% primas, incluidas acciones y opciones de la empresa. posee directamente un 28.52% de las acciones de la empresa, por valor de $156.09M. La antigüedad media del equipo directivo y de la junta directiva es de 4.7 años y 3.8 años, respectivamente.
Información clave
Ming Hsieh
Chief Executive Officer (CEO)
US$5.3m
Compensación total
| Porcentaje del salario del CEO | 18.8% |
| Permanencia del CEO | 8.5yrs |
| Participación del CEO | 28.5% |
| Permanencia media de la dirección | 4.7yrs |
| Promedio de permanencia en la Junta Directiva | 3.8yrs |
Actualizaciones recientes de la dirección
Recent updates
Fulgent Genetics: An NCAV Pick With Profit And Growth Potential
Sep 25Fulgent Genetics: Core Growth Re-Acceleration Will Be The Critical Catalyst
Sep 09Some Shareholders Feeling Restless Over Fulgent Genetics, Inc.'s (NASDAQ:FLGT) P/S Ratio
Jul 17
Fulgent Genetics: Growth Is Returning
Jun 06Shareholders May Be Wary Of Increasing Fulgent Genetics, Inc.'s (NASDAQ:FLGT) CEO Compensation Package
May 10Analysts Have Been Trimming Their Fulgent Genetics, Inc. (NASDAQ:FLGT) Price Target After Its Latest Report
May 07Are Investors Undervaluing Fulgent Genetics, Inc. (NASDAQ:FLGT) By 32%?
Mar 01Fulgent Genetics: Buy Growth Ahead Below Liquidation Value
Feb 21Subdued Growth No Barrier To Fulgent Genetics, Inc.'s (NASDAQ:FLGT) Price
Jan 17Is Fulgent Genetics (NASDAQ:FLGT) Using Debt Sensibly?
Dec 14Fulgent Genetics (NASDAQ:FLGT) Has Debt But No Earnings; Should You Worry?
Aug 09Analysts Have Been Trimming Their Fulgent Genetics, Inc. (NASDAQ:FLGT) Price Target After Its Latest Report
May 09Fulgent Genetics (NASDAQ:FLGT) Is Looking To Continue Growing Its Returns On Capital
Apr 19Why We Like The Returns At Fulgent Genetics (NASDAQ:FLGT)
Jan 15Does Fulgent Genetics (NASDAQ:FLGT) Have A Healthy Balance Sheet?
Dec 28What Does The Future Hold For Fulgent Genetics, Inc. (NASDAQ:FLGT)? These Analysts Have Been Cutting Their Estimates
Nov 16Why Fulgent Genetics, Inc. (NASDAQ:FLGT) Could Be Worth Watching
Oct 27Wait For Fulgent Genetics To Grow Up
Oct 13We Like Fulgent Genetics' (NASDAQ:FLGT) Returns And Here's How They're Trending
Sep 19Fulgent Genetics (NASDAQ:FLGT) Seems To Use Debt Rather Sparingly
Sep 05Fulgent Genetics: Poised To Survive Its Post-Covid Hangover
Jul 26Fulgent Genetics, Inc.'s (NASDAQ:FLGT) Low P/E No Reason For Excitement
Jul 21Fulgent Genetics (NASDAQ:FLGT) Is Investing Its Capital With Increasing Efficiency
Jun 04Fulgent Is Putting Its Cash Bonanza To Work
May 15These 4 Measures Indicate That Fulgent Genetics (NASDAQ:FLGT) Is Using Debt Safely
May 04Fulgent Genetics: Now The Going Could Get Much Tougher
Apr 10Fulgent Genetics: COVID Bolstered The Underlying Business
Mar 17Fulgent Genetics: Somewhat Disappoints With A Marked Slowdown In Its NGS Business
Feb 27Fulgent Genetics Stock: 35% Off Its Recent Highs - It Is Now A Buy
Feb 09Fulgent Genetics: Sell Volatility
Jan 26Análisis de compensación del CEO
| Fecha | Compensación total | Salario | Ingresos de la empresa |
|---|---|---|---|
| Sep 30 2024 | n/a | n/a | -US$165m |
| Jun 30 2024 | n/a | n/a | -US$163m |
| Mar 31 2024 | n/a | n/a | -US$166m |
| Dec 31 2023 | US$5m | US$1m | -US$168m |
| Sep 30 2023 | n/a | n/a | -US$64m |
| Jun 30 2023 | n/a | n/a | -US$49m |
| Mar 31 2023 | n/a | n/a | -US$26m |
| Dec 31 2022 | US$5m | US$948k | US$143m |
| Sep 30 2022 | n/a | n/a | US$272m |
| Jun 30 2022 | n/a | n/a | US$392m |
| Mar 31 2022 | n/a | n/a | US$461m |
| Dec 31 2021 | US$6m | US$664k | US$507m |
| Sep 30 2021 | n/a | n/a | US$569m |
| Jun 30 2021 | n/a | n/a | US$493m |
| Mar 31 2021 | n/a | n/a | US$417m |
| Dec 31 2020 | US$248k | US$240k | US$214m |
| Sep 30 2020 | n/a | n/a | US$48m |
| Jun 30 2020 | n/a | n/a | US$3m |
| Mar 31 2020 | n/a | n/a | -US$459k |
| Dec 31 2019 | US$240k | US$240k | -US$411k |
| Sep 30 2019 | n/a | n/a | -US$2m |
| Jun 30 2019 | n/a | n/a | -US$4m |
| Mar 31 2019 | n/a | n/a | -US$6m |
| Dec 31 2018 | US$240k | US$240k | -US$6m |
| Sep 30 2018 | n/a | n/a | -US$5m |
| Jun 30 2018 | n/a | n/a | -US$6m |
| Mar 31 2018 | n/a | n/a | -US$5m |
| Dec 31 2017 | US$240k | US$240k | -US$3m |
Compensación vs. Mercado: La compensación total de Ming($USD5.31M) está por encima de la media de empresas de tamaño similar en el mercado US ($USD2.11M).
Compensación vs. Ingresos: La compensación de Ming ha aumentado mientras la empresa no es rentable.
CEO
Ming Hsieh (68 yo)
8.5yrs
Permanencia
US$5,309,167
Compensación
Mr. Ming Hsieh has been an Independent Director of Fortinet, Inc. since April 2013. He is the Founder of Fulgent Genetics, Inc. and had been its President until May 2022 & serves as its Chief Executive Off...
Equipo directivo
| Nombre | Posición | Permanencia | Compensación | Propiedad |
|---|---|---|---|---|
| Chairman & CEO | 8.5yrs | US$5.31m | 28.52% $ 156.1m | |
| COO & President | 6.6yrs | US$1.79m | 1.42% $ 7.8m | |
| Chief Financial Officer | 8.8yrs | US$1.78m | 0.40% $ 2.2m | |
| Chief Scientific Officer & Laboratory Director | 8.2yrs | US$1.49m | 2.8% $ 15.3m | |
| General Counsel & Chief Privacy Officer | 2.5yrs | sin datos | sin datos | |
| VP of Operations & Compliance and GM of Houston Office | 4.1yrs | sin datos | sin datos | |
| Vice President of Business Development & Sales | 9.8yrs | sin datos | sin datos | |
| Vice President of Human Resources | 2.5yrs | sin datos | sin datos | |
| Chief Commercial Officer | 4.7yrs | sin datos | sin datos | |
| Chief Medical Officer | 3.5yrs | sin datos | sin datos | |
| President & Chief Scientific Officer of Fulgent Pharma | 2yrs | sin datos | sin datos |
4.7yrs
Permanencia media
58yo
Promedio de edad
Equipo directivo experimentado: El equipo directivo de FLGT se considera experimentado (4.7 años antigüedad media).
Miembros de la Junta
| Nombre | Posición | Permanencia | Compensación | Propiedad |
|---|---|---|---|---|
| Chairman & CEO | 8.5yrs | US$5.31m | 28.52% $ 156.1m | |
| Independent Non-Employee Director | 1.8yrs | US$625.60k | 0.0039% $ 21.2k | |
| Independent Director | 5.3yrs | US$270.50k | 0.061% $ 333.8k | |
| Independent Non-Employee Director | 2.3yrs | US$268.50k | 0.0078% $ 42.6k |
3.8yrs
Permanencia media
67yo
Promedio de edad
Junta con experiencia: La junta directiva de FLGT se considera experimentada (3.8 años de antigüedad promedio).